Ventricular Tachycardia Cohort
1 other identifier
observational
1,500
0 countries
N/A
Brief Summary
The goal of this observational study is to detect the long-term risk of a composite endpoint event in adult patients with ventricular tachycardia (VT) who are managed with catheter ablation or non-ablation management (including modern drug therapy and/or ICD therapy).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2025
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 24, 2025
CompletedStudy Start
First participant enrolled
September 1, 2025
CompletedFirst Posted
Study publicly available on registry
September 2, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2029
September 2, 2025
August 1, 2025
4 years
August 24, 2025
August 24, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Composite of death and recurrence of ventricular tachycardia
1 year
Study Arms (1)
Normal treatment
Treatment without intervention of catheter ablation or Implantable cardioverter defibrillator.
Interventions
Treatment with intervention of catheter ablation or Implantable cardioverter defibrillator.
Eligibility Criteria
Patients diagnosed with ventricular tachycardia
You may qualify if:
- Sustained ventricular tachycardia (VT), defined as VT lasting ≥30 seconds or requiring intervention due to hemodynamic compromise within 30 seconds; or Clinically significant non-sustained VT (NSVT) where the treating clinician has determined that therapeutic intervention is necessary.
You may not qualify if:
- Concurrent participation in any interventional clinical trial that, in the judgment of the investigator, could interfere with the data collection or outcome assessment of this observational study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 8 Years
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 24, 2025
First Posted
September 2, 2025
Study Start
September 1, 2025
Primary Completion (Estimated)
September 1, 2029
Study Completion (Estimated)
December 1, 2029
Last Updated
September 2, 2025
Record last verified: 2025-08